Skip to main content
2025 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Andre Hermans, PhD (he/him/his)

Executive Director
Merck & Co., Inc.
Rahway, New Jersey

Andre Hermans is Executive Director in the Small Molecule Analytical Research and Development Division at Merck & Co. in Rahway, NJ. He received is PhD in Analytical Chemistry from the University of North Carolina in Chapel Hill before joining Merck in 2007. During his time at Merck, Andre supported analytical method development and process development in the small molecule solid oral dosage area throughout all phases of drug development. In this function, he authored several IND and NDA applications mainly for oral formulations containing amorphous solid dispersions. Additionally, he is co-leading Merck’s efforts around in-vivo predictive technologies, dissolution innovations, and clinically relevant dissolution specifications. Andre is a member of the IQ dissolution and ICH Q3D working groups, a member of the USP expert panel for “New Advancements in Performance Testing,” and former chair of the AAPS In-vitro testing dissolution community. He is the author of many publications in the field of dissolution testing and clinical relevance.

Disclosure information not submitted.

Presentation(s):